SERA

Sera Prognostics Inc. Class A Common Stock (SERA)

Stock · NASDAQ · Health Care

$2.06as of 10/16/2026

Price chart

Open in TradingView

Active signals

Support Confirmation52.2%Revenue-Price Divergence (6M)43.5%200 SMA Touch0.0%
Support level
$1.98
Industry
Medical Specialities

SERA Signal Track Record

How signals performed across all stocks →

What SERA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike46-2.9%41%
Bollinger Band Breakdown21-1.6%48%
Bollinger Band Breakout21-6.0%38%
200-Day Moving Average TouchActive now11-3.5%45%
Any 20-session window (baseline)-2.1%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About SERA

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based bi…

Sector
Health Care
Industry
Medical Specialities
Employees
71

Fundamentals

1-day range
$2.03$2.06
Market cap
$78.32M
P/E (trailing)
—
P/E (forward)
-3.85
EPS (trailing)
$-0.66
Dividend yield
—
Beta
1.09
Avg. volume
25.5K
52-week range
$1.56$3.95
Next earnings: November 16, 2026 · EPS estimate $-0.14confirmed

How Sera Prognostics Inc. Class A Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$81.0KSG&A$23.25M (28704%)R&D$13.17M (16260%)SERA

Source: 10-K filed Mar 18, 2026 · via SEC EDGAR / Finnhub

Operating Income-$36.50M(-45067%)

Forecasts

2 analyst ratings

Buy 90%
Hold 10%
Sell 0%
1-year price forecast
High
$6
+191.3%
Median
$5.5
+167.0%
Low
$5
+142.7%

Sera Prognostics Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

  • SERA
    Sera Prognostics Inc. Class A Common Stock
    $2.06
    ▲ 1.48%
    Market cap $78.32MP/E —
    $1.56$3.95
  • BNR
    Burning Rock Biotech Limited American Depositary Shares
    $12.9
    ▼ 17.31%
    Market cap $93.65MP/E —
    $6.79$41.72
  • TLSIW
    TriSalus Life Sciences Inc. Warrant
    $0.8799
    ▼ 2.23%
    Market cap $101.95MP/E —
    $0.4405$1.85
  • KEQU
    Kewaunee Scientific Corporation Common Stock
    $32.93
    ▲ 2.30%
    Market cap $108.73MP/E 11.26
    $32$46.57
  • MDXH
    MDxHealth SA Ordinary Shares
    $0.207
    ▼ 65.73%
    Market cap $22.50MP/E —
    $0.4$5.33
  • YDESW
    YD Bio Limited Warrants
    $0.599
    ▼ 9.24%
    Market cap $16.29MP/E —
    $0.1904$2.5
  • ADVB
    Advanced Biomed Inc. Common Stock
    $3.98
    ▼ 18.44%
    Market cap $12.29MP/E 1.53
    $3.61$24.23

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
412.1K
Disposed
31.6K

Institutional Ownership

March 31, 2026

Total shares held
19.78M
Total value held
$39.94M
Institutional holders
53
Top holders this quarter
  • Unknown5.50M
  • Unknown3.31M
  • Unknown2.55M
  • Unknown2.40M
  • Unknown1.65M
  • Unknown1.20M
  • Unknown536.8K
  • Unknown363.6K
  • Unknown314.9K
  • Unknown263.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.